These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 6502234

  • 21. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7621-31. PubMed ID: 16234523
    [Abstract] [Full Text] [Related]

  • 22. Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine.
    Rodriguez LA, Prados M, Fulton D, Edwards MS, Silver P, Levin V.
    Neurosurgery; 1988 Apr 20; 22(4):691-3. PubMed ID: 3374780
    [Abstract] [Full Text] [Related]

  • 23. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.
    Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR.
    N Engl J Med; 1993 Jun 17; 328(24):1725-31. PubMed ID: 8388548
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Salvage chemotherapy for recurrent primary brain tumors in children.
    van Eys J, Baram TZ, Cangir A, Bruner JM, Martinez-Prieto J.
    J Pediatr; 1988 Sep 17; 113(3):601-6. PubMed ID: 3411410
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
    Fouladi M, Blaney SM, Poussaint TY, Freeman BB, McLendon R, Fuller C, Adesina AM, Hancock ML, Danks MK, Stewart C, Boyett JM, Gajjar A.
    Cancer; 2006 Nov 01; 107(9):2291-7. PubMed ID: 17019740
    [Abstract] [Full Text] [Related]

  • 28. Management of medulloblastoma and ependymoma in infants: a single-institution long-term retrospective report.
    Massimino M, Gandola L, Cefalo G, Lasio G, Riva D, Fossati-Bellani F, Gianni MC, Luksch R, Tesoro-Tess JD, Lombardi F.
    Childs Nerv Syst; 2000 Jan 01; 16(1):15-20. PubMed ID: 10672424
    [Abstract] [Full Text] [Related]

  • 29. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
    Eagan RT, Dinapoli RP, Hermann RC, Groover RV, Layton DD, Scott M.
    Cancer Treat Rep; 1982 Aug 01; 66(8):1647-9. PubMed ID: 7105055
    [No Abstract] [Full Text] [Related]

  • 30. Response to vincristine of recurrent brain tumors in children.
    Rosenstock JG, Evans AE, Schut L.
    J Neurosurg; 1976 Aug 01; 45(2):135-40. PubMed ID: 939971
    [Abstract] [Full Text] [Related]

  • 31. Treatment of patients with recurrent primary brain tumors with AZQ.
    Schold SC, Friedman HS, Bjornsson TD, Falletta JM.
    Neurology; 1984 May 01; 34(5):615-9. PubMed ID: 6538653
    [Abstract] [Full Text] [Related]

  • 32. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.
    Finlay JL.
    Bone Marrow Transplant; 1996 Dec 01; 18 Suppl 3():S1-5. PubMed ID: 8971398
    [Abstract] [Full Text] [Related]

  • 33. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
    Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):374-9. PubMed ID: 15667955
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors.
    Rosenblum ML, Reynolds AF, Smith KA, Rumack BH, Walker MD.
    J Neurosurg; 1973 Sep 01; 39(3):306-14. PubMed ID: 4354763
    [No Abstract] [Full Text] [Related]

  • 37. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.
    Strother DR, Lafay-Cousin L, Boyett JM, Burger P, Aronin P, Constine L, Duffner P, Kocak M, Kun LE, Horowitz ME, Gajjar A.
    Neuro Oncol; 2014 Mar 01; 16(3):457-65. PubMed ID: 24335695
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar 01; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.